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Effect of electronic medication reconciliation at the time
of hospital discharge on inappropriate medication use
in the community: an interrupted time-series analysis
Blayne Welk MD MSc, Lauren Killin MSc, Jennifer N. Reid MSc, Kelly K. Anderson PhD,
Salimah Z. Shariff PhD, Andrew Appleton MD, Glen Kearns HBA MRE, Amit X. Garg MD PhD

Abstract
Background: It is unclear if enhanced electronic medication reconciliation systems can reduce inappropriate medication use and
improve patient care. We evaluated trends in potentially inappropriate medication use after hospital discharge before and after adoption of an electronic medication reconciliation system.
Methods: We conducted an interrupted time-series analysis in 3 tertiary care hospitals in London, Ontario, using linked health care
data (2011–2019). We included patients aged 66 years and older who were discharged from hospital. Starting between Apr. 13 and
May 21, 2014, physicians were required to complete an electronic medication reconciliation module for each discharged patient. As a
process outcome, we evaluated the proportion of patients who continued to receive a benzodiazepine, antipsychotic or gastric acid
suppressant as an outpatient when these medications were first started during the hospital stay. The clinical outcome was a return to
hospital within 90 days of discharge with a fall or fracture among patients who received a new benzodiazepine or antipsychotic during
their hospital stay. We used segmented linear regression for the analysis.
Results: We identified 15 932 patients with a total of 18 405 hospital discharge episodes. Before the implementation of the electronic
medication reconciliation system, 16.3% of patients received a prescription for a benzodiazepine, antipsychotic or gastric acid suppressant after their hospital stay. After implementation, there was a significant and immediate 7.0% absolute decline in this proportion
(95% confidence interval [CI] 4.5% to 9.5%). Before implementation, 4.1% of discharged patients who newly received a benzodiaz
epine or antipsychotic returned to hospital with a fracture or fall within 90 days. After implementation, there was a significant and
immediate 2.3% absolute decline in this outcome (95% CI 0.3% to 4.3%).
Interpretation: Implementation of an electronic medication reconciliation system in 3 tertiary care hospitals reduced potentially inappropriate medication use and associated adverse events when patients transitioned back to the community. Enhanced electronic
medication reconciliation systems may allow other hospitals to improve patient safety.

M

edication reconciliation is the process of ensuring a patient’s medication record is updated with
the most appropriate information. This is
important during transitions of care to prevent unintended
errors that can lead to patient harm. Several systematic
reviews have shown that medication reconciliation reduces
medication discrepancies, which may reduce adverse
patient outcomes, hospital readmissions, emergency
department visits and excess health care costs.1–3 For example, medications that were intended for use only while a
patient was admitted to hospital can cause harm if they are
inadvertently prescribed to the patient for use after hospital
discharge.4 Medication reconciliation is a required operational practice by Accreditation Canada, and Health Quality
Ontario identified it as a priority indicator of safe and efficient clinical care.5

© 2021 CMA Joule Inc. or its licensors

Initially, medication reconciliation was performed using
a pen-and-paper process. However, the introduction of
hospital-based electronic medical record (EMR) systems has
led to the creation of enhanced electronic medication reconciliation systems that interact directly with the patient’s
hospital medication records. Canadian health care providers
have invested billions of dollars in hospital-based EMRs
with the intention of improving hospital efficiency and
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Research
patient outcomes. 6 However, the effect of the different
components of commercial EMR systems, such as medication reconciliation systems, on patient care is unclear. 7
Previous studies have reported conflicting results of
whether electronic medication reconciliation systems can
reduce medication discrepancies, and little evidence has
shown that they improve clinically relevant outcomes.8,9
In 2014, regional hospitals in London, Ontario, upgraded
their EMR and added an enhanced electronic medication reconciliation system. Our objective was to evaluate the trends in
potential inappropriate medication use after hospital discharge before and after adoption of this medication reconciliation system. We evaluated both a process outcome (i.e., the
proportion of patients aged 66 years and older who received a
benzodiazepine, antipsychotic or gastric acid suppressant as an
outpatient,4,10 when these medications were first started during the hospital stay) and a clinical outcome (i.e., the proportion of patients who returned to hospital with a fall or fracture
among those who received a new benzodiazepine or anti
psychotic during their hospital stay). We hypothesized that
there would be less continued outpatient use of these medications, and fewer falls and fractures after implementation of the
enhanced electronic medication reconciliation system.

Methods
Study design and setting

All residents of Ontario have access to a single, universal
health care system. We conducted a retrospective, interrupted
time-series analysis of routinely collected health data from
Jan. 1, 2011, to Mar. 26, 2019, from the 3 hospitals in London, Ont., St. Joseph’s Health Care London, and the University and Victoria Hospital campuses of London Health Sciences Centre. These hospitals are large academic centres and,
in total, have about 2000 inpatient beds for acute and chronic
care. They provide tertiary care to a catchment area of almost
2 million people. We report study findings using the recommended guideline for observational studies that use routinely
collected health data.11

Data sources

The 3 London hospitals use an EMR from Cerner, a supplier
of widely used EMR solutions. We used unique encoded
identifiers to link data from the hospitals’ Cerner EMR to
12 health care databases held at ICES, including the Canadian
Institute for Health Information’s Discharge Abstract Database and Same Day Surgery Database, the Ontario Health
Insurance Plan Database, the National Ambulatory Care
Reporting System Database, the Registered Persons Database
and the Ontario Drug Benefit Database. These data sets were
analyzed at ICES. Additional information on the databases
and their validity is provided in Appendix 1, Section 1, available at www.cmajopen.ca/content/9/4/E1105/suppl/DC1.
We used these data sources to measure patient characteristics, prescription drug use, covariate information and outcome data. Variable definitions and the relevant administrative codes are in Appendix 1, Section 2.
E1106
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Enhanced electronic medication reconciliation
system
The hospitals upgraded the existing Cerner EMR on
Apr. 13, 2014 (University Hospital), Apr. 27, 2014 (Victoria
Hospital), and May 21, 2014 (St. Joseph’s Hospital). This
upgrade was implemented across each of the hospitals in a
single day on the specified dates, after which physicians used
the new electronic medication reconciliation system, in the
Cerner EMR.
This system replaced a long-standing paper-based process. The paper-based process required the physician or
pharmacist to copy medications manually from the medication administration record to a carbon-copy form and use
tick boxes to indicate changes. The new electronic system
required physicians to complete a computerized discharge
module and explicitly indicate whether patients should
continue each medication that was ordered during their
hospital stay.

Identification of hospitalization discharge episodes

Using the EMR data from each hospital, we identified all
patients aged 66 years and older (i.e., eligible for governmentfunded outpatient medication coverage) who were discharged
to home or long-term care during the study period. We
divided discharge episodes from our consecutive 98-month
study time period into 2-month intervals. Intervals 1–19 represented the period before use of the enhanced electronic
medication reconciliation system (Feb. 1, 2011, to Mar. 31,
2014), and intervals 20–49 represented the period with its use
(Apr. 1, 2015, to Mar. 26, 2019).
We included only hospital discharge episodes in which
the patient was newly dispensed a medication of interest
(i.e., a benzodiazepine, antipsychotic or gastric acid suppressant) during their hospital stay. We excluded discharge
episodes where the patient had inaccurate data characteristics, died during their hospitalization or within 5 days of
discharge, had a length of stay of zero days, had an admission to a hospital in the previous 6 months (to reduce carryover effects from the previous admission) or were readmitted to hospital or returned to an emergency department
within 5 days of discharge (as they may not have had an
opportunity to fill discharge prescriptions). We also
excluded discharge episodes if the patient had a diagnosis
from a hospital admission in the previous 6 months that
suggested the medications of interest would be appropriate
to continue as an outpatient (e.g., we excluded patients with
a diagnosis of gastrointestinal bleed, as the use of a proton
pump inhibitor after discharge would likely be appropriate).
For a full list of these conditions and coding algorithms, see
Appendix 1, Section 3.
To maximize data quality, we retained only records for
which the admission and discharge dates recorded in
Cerner matched those in the Discharge Abstract Database.
The unit of analysis was a hospital discharge; patients
could therefore be included multiple times if they were
rehospitalized more than 6 months after their last
hospitalization.

Research
Outcomes

We defined 3 classes of medications a priori as potentially
inappropriate, namely benzodiazepines, antipsychotics and
gastric acid suppressants. Benzodiazepines are sedatives
that are commonly used to treat temporary hospital-based
sleep disturbances, but can lead to cognitive impairment,
sedation, falls, and dependence or addiction.12 Antipsychotics are often used off-label for agitation and hospitalinduced delirium. Long-term use is associated with anticholinergic effects, tardive dyskinesia, falls, arrhythmias
and cognitive decline.13 Gastric acid suppressants are often
prescribed for general, hospital-based gastrointestinal
symptoms. Long-term use is associated with an increased
risk of pneumonia, infection by Clostridium difficile, fracture
risk (with use for more than a year), hypomagnesemia and
serious drug interactions.14,15 Individual medications are
listed in Appendix 1, Section 4. We selected these medications because of their frequency of use in hospitalized,
older adult patients,4 their inclusion in the Beers Criteria
of potentially inappropriate medications for older adults10
and their potential for clinically important, adverse drug
reactions.
The primary process outcome was the proportion of people who filled a prescription for 1 of these medications in the
outpatient setting within 5 days of hospital discharge when
these medications were first started during the hospital stay.
Patients could be prescribed more than 1 of these medication classes.
The primary clinical outcome was a hospital visit for a
fall or fracture within 90 days of hospital discharge among
the subgroup of patients who received a benzodiazepine or
an antipsychotic in hospital. Falls and fractures in older
adults are important and relevant outcomes to patients
and clinicians because of their association with traumatic
brain injury, institutionalization and death.16–18 Details on
how we defined this outcome are listed in Appendix 1,
Section 5.

Statistical analysis

We compared the patient and hospital admission characteristics for hospital discharge episodes before and after implementation of the electronic medication reconciliation system using standardized differences. 19 We assessed the
association between implementation and outcomes using
segmented linear regression analysis of 19 intervals before,
and 30 intervals after, implementation. This number of
intervals was adequate for an interrupted time-series analysis.20 The model included regression coefficients to determine whether there was a significant trend (slopes before
and after use of an electronic medication reconciliation system) or a significant interval change (an immediate change
after system implementation).
We confirmed model assumptions of homoscedasticity,
linearity and normality graphically. We confirmed the
absence of autocorrelation using the Durbin–Watson statistic,
and used the Cook D statistic to ensure there were no unusual
or influential data points.21 We used the χ2 test to assess dif-

ferences in proportions. We conducted statistical analyses
using SAS 9.4, and considered 2-sided p values less than 0.05
statistically significant.

Ethics approval

This project was approved by the Western University
Research Ethics Board (#112138).

Results
We identified 15 932 patients who had a total of 18 405 hospital discharge episodes (Figure 1). Comorbidities were frequent in our patient population (Table 1); the patient characteristics of the hospital discharge episodes before and after
implementation of the electronic medication reconciliation
system were similar, aside from a lower proportion of
ischemic heart disease after implementation, and a slightly
lower number of previous specialist visits.
The hospital admission characteristics were also similar
between the 2 time periods, aside from the length of stay,
which was a median of 1 day shorter after implementation of
the electronic medication reconciliaton system (Table 2). The
top 3 most common diagnoses at admission (representing
about 15% of admissions) were the same both before and
after implementation, namely coronary artery disease, osteoarthritis and aortic valve stenosis.
A potentially inappropriate study medication was dispensed in the outpatient setting in 2641 (14.3%) of 18 405
hospital discharge episodes. After the implementation of the
electronic medication reconciliation system, there was a sudden and significant decline in hospital discharges associated
with such dispensing (–7.00%, 95% confidence interval [CI]
–9.50 to –4.50) and a small but significant change in the slope
time (–0.40%, 95% CI –0.61 to –0.19) per 2-month interval
(details in Table 3 and Figure 2). The outpatient medication
prescriptions that declined most after implementation were
benzodiazepines and gastric acid suppressants (Table 4).
There were 5240 hospital discharge episodes (4809 patients)
in which patients were newly dispensed an antipsychotic or a
benzodiazepine during their hospital stay (cohort details shown
in Appendix 1, Section 6). After these hospital discharge episodes, 175 (3.3%) presented to a hospital or emergency department with a fall or fracture within 90 days of hospital discharge.
There was a significant drop in falls or fractures immediately
after implementation of the electronic system (–2.32%, 95% CI
–4.30 to –0.34), and the change in slope was nonsignificant
(Table 3 and Figure 3).

Interpretation
When patients move between care settings, there is a
potential for unintentional medication errors, and discharge from hospital is a particularly risky transition.2 We
report on the effect of an enhanced electronic medication
reconciliation system that was introduced through a commercial EMR upgrade in 3 regional hospitals. We found
the introduction of the electronic system was associated
CMAJ OPEN, 9(4)
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All patients discharged between
Jan. 1, 2011 and Mar. 26, 2019
n = 896 999
Excluded
•
•
•
•

LOS < 1 d n = 559 714
Age < 55 yr n = 208 896
Encounter not inpatient n = 18 253
Not exposed to a medication of interest in hospital n = 26 904

Cerner cohort
n = 85 232

Data integration and linkage at ICES
Excluded
•
•
•
•
•
•
•

Age < 66 yr or non-Ontario residents n = 26 724
Death before or within 5 d of discharge n = 5151
Readmitted within 5 d of discharge n = 837
Mental health or gastrointestinal primary admission n = 13 605
Use of a study medication in the 6 mo before discharge n = 22 151
Return to emergency room within 5 d of discharge n = 715
Discharged in January n = 117

Final cohort
Patients n = 15 932
Encounters n = 18 405

Before EEMRS
Patients n = 5455
Encounters n = 5971

After EEMRS
Patients n = 10 974
Encounters n = 12 434

Figure 1: Study flow diagram. The pre-implementation period (“before EEMRS”) includes 19 2-month intervals (Feb, 1, 2011, to Mar. 31, 2014),
and the postimplementation period (“after EEMRS”) includes 30 2-month intervals (Apr. 1, 2014, to Mar. 26, 2019). Note: EEMRS = electronic
medication reconciliation systems, LOS = length of stay.

with an immediate, significant decrease in the proportion
of older patients who filled prescriptions for potentially
inappropriate, unsafe medications (i.e., benzodiazepines,
antipsychotics and gastric acid suppressants) after hospital
discharge. Importantly, in the subset of patients who were
prescribed benzodiazepines or antipsychotics, there was a
corresponding immediate drop in the proportion of
patients who returned to hospital with a fall or fracture,
which is a known adverse effect of both these medications
in older adults.12,13
Although many interventions have been developed to
improve medication reconciliation, most are multifaceted
approaches that require pharmacist involvement, postdischarge
follow-up or patient education.22 Despite substantial technological upgrades in the medication reconciliation process, only
E1108
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a few studies have evaluated commercially available electronic medication reconciliation systems, and limited evidence has shown that these updates lead to improvements in
patient care.23,24 For example, the MARQUIS study was a
multicentre, quality improvement study that was carried out
at 5 hospitals in the United States. The implementation of
11 interventions designed to support medication reconciliation resulted in a small reduction in medication discrepancies, but there was no significant reduction in potentially
harmful discrepancies.25 A cluster-randomized study from
selected hospital units at McGill University Health Centre
showed that an electronic tool that integrated community
and hospital pharmacy records and introduced a medication
reconciliation system led to a reduction in medication discrepancies, but did not reduce adverse drug events or future

Research
Table 1: Patient characteristics of hospital discharge episodes before and after the implementation of
a hospital-based electronic medication reconciliation program
No. (%) of patients*

Variable

Before
implementation†
n = 5971

After
implementation‡
n = 12 434

Standardized
difference, %

Demographics
Age, yr, median (IQR)

74 (69–80)

74 (69–80)

5

Sex, male

3350 (56.1)

6853 (55.1)

2

Lowest income quintile

1052 (17.6)

2352 (18.9)

3

Highest income quintile

1334 (22.3)

2544 (20.5)

5

Long-term care resident

41 (0.7)

91 (0.7)

1

0 (0–1)

0 (0–1)

0

438 (7.3)

886 (7.1)

1

Comorbidities
Charlson comorbidity score, median
(IQR)
Chronic obstructive pulmonary disease
Diabetes

485 (8.1)

745 (6.0)

8

Hypertension

766 (12.8)

1235 (9.9)

9

Ischemic heart disease

1470 (24.6)

2452 (19.7)

11

64 (1.1)

192 (1.5)

4

Liver disease
Inflammatory bowel disease

707 (11.8)

1459 (11.7)

0

Renal disease

394 (6.6)

923 (7.4)

3

Arthritis

38 (0.6)

95 (0.8)

2

Stroke

161 (2.7)

362 (2.9)

1

Cerebrovascular disease

214 (3.6)

464 (3.7)

1

Dementia

25 (0.4)

60 (0.5)

1

947 (15.9)

2043 (16.4)

2

No. of outpatient internal medicine
specialist visits in previous year, median
(IQR)

0 (0–1)

0 (0–1)

21

No. of primary care visits in previous
year, median (IQR)

3 (1–8)

3 (1–8)

0

7 (4–11)

7 (4–11)

1

2075 (34.8)

4249 (34.2)

1

Congestive heart failure
Previous health care utilization

Medication use
No. of medications in previous year,
median (IQR)
Polypharmacy at admission (≥ 10
different daily prescription medications in
the last year)
Note: IQR = interquartile range.
*Unless indicated otherwise.
†Before Mar. 31, 2014.
‡After Apr. 1, 2014.

hospital encounters.8 In contrast, our study focused on 3 specific medication classes that have the potential to cause harm,
rather than all possible medications. Our results provide evidence of an added benefit from an electronic medication reconciliation system that, when shared with physicians and
health administrators at other hospitals, may improve buy-in
for adopting such a system.

Our study is timely and relevant, as many Canadian hospitals are deliberating whether to adopt an electronic medication reconciliation system.26 Future efforts should continue to evaluate the clinical benefit of EMR systems in
Canada. Theoretical benefits associated with new systems
and processes should continue to be evaluated to ensure they
are usable and improve patient care. New EMR modules
CMAJ OPEN, 9(4)
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Table 2: Hospitalization characteristics of hospital discharge episodes before and after the
implementation of a hospital-based electronic medication reconciliation program
No. (%) of patients*
Before
implementation
n = 5971

After
implementation
n = 12 434

Standardized
difference, %

7 (4–12)

6 (3–10)

21

Medical

1783 (29.9)

4098 (33.0)

7

Surgical

3957 (66.3)

7850 (63.1)

7

231 (3.9)

486 (3.9)

0

Variable
Hospital length of stay, median
(IQR)
Type of inpatient service

Other
Transfer from ED to inpatient

2403 (40.2)

4699 (37.8)

5

ICU admission

1727 (28.9)

3289 (26.5)

6

Surgery or procedure
performed

5247 (87.9)

11 254 (90.5)

8

184 (3.1)

249 (2.0)

7

Discharged to long-term care

Note: ED = emergency department, ICU = intensive care unit, IQR = interquartile range.
*Unless indicated otherwise.

Table 3: Segmented regression analysis for the primary process and clinical outcomes before
and after implementation of an enhanced electronic medication reconciliation system*
Slope, % (95% CI)
Outcome

Before implementation
(per 2-mo interval)

After implementation
(per 2-mo interval)

Absolute change
immediately after
implementation, % (95% CI)

Process

0.42 (0.20 to 0.64)

–0.40 (–0.61 to –0.19)

–7.00 (–9.50 to –4.50)

Clinical

0.06 (–0.09 to 0.21)

–0.02 (–0.11 to 0.17)

–2.32 (–4.30 to –0.34)

Note: CI = confidence interval.
*The primary process outcome was receipt of a medication of interest within 5 days of discharge. The primary clinical
outcome was a hospital visit for a fall or fracture within 90 days of hospital discharge among patients who received a
benzodiazepine or an antipsychotic in hospital.

that require physician completion should be selected judiciously, as these new processes are linked to changes in
workflow and additional administrative tasks that can lead to
burnout and frustration in the workplace.27

Limitations

We used routinely collected data to conduct our study; therefore, there is a possibility of misclassification of study variables. The continued use of study medications after hospital
discharge was likely appropriate in some patient discharges in
our study, and thus we used the term “potentially inappropriate medication use.” We could look only at dispensed prescriptions; therefore, we may have underestimated the outcome if patients received prescriptions they did not fill. The
use of segmented regression is an appropriate method for
E1110
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evaluating the longitudinal effect of an intervention; however, it is still a quasiexperimental approach that is susceptible to confounding. It is possible that other prescribing
changes or hospital system changes may have been occurring during the same period and may have contributed to
the effect we observed. The enhanced electronic medication
reconciliation system likely had increased uptake with time,
and thus we may have underestimated its effectiveness in
the initial time periods after implementation. Finally, this
study was carried out in older adults, and represents the
impact of a transition from a hospital-specific, paper-based
medication reconciliation process to a commercially implemented electronic system. These results may not be generalizable to other patient populations, or other implementation processes.
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Figure 2: Proportion of hospital discharge episodes associated with a prescription filled for a benzodiazepine, antipsychotic or gastric acid suppressant in the outpatient setting, in 2-month intervals from Feb. 1, 2011, to Mar. 26, 2019. The dotted line represents the implementation date
of the electronic medication reconciliation system.

Table 4: Proportion of hospital discharge episodes with a primary process outcome (receipt of a medication of
interest within 5 days of discharge)
No. of hospitalization episodes with
medication

No. (%) of discharge episodes with
medication

Before
implementation

After
implementation

Before
implementation

After
implementation

Absolute
difference, %
(95% CI)

All medications

5971

12 434

971 (16.3)

1670 (13.4)

–2.9 (–3.9 to –1.7)

Antipsychotics

438

986

20 (4.6)

43 (4.4)

–0.2 (–2.5 to 2.1)

Benzodiazepines

3047

6190

95 (3.1)

129 (2.1)

–1.0 (–1.8 to –0.3)

Gastric acid
suppressants

4438

8727

855 (19.3)

1489 (17.1)

–2.2 (–3.6 to –0.8)

Medication

Note: CI = confidence interval.

Conclusion

The implementation of a commercially available,
enhanced electronic medication reconciliation system in
3 Canadian hospitals was associated with a significant and

immediate decrease in the proportion of patients who
filled a potentially inappropriate prescription for benzo
diazepines, antipsychotics or gastric acid suppressants
when they transitioned back to the community. Among
CMAJ OPEN, 9(4)
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Figure 3: Proportion of hospital discharge episodes in the subgroup exposed to a benzodiazepine or antipsychotic that were associated with a
fall or fracture within 90 days of hospital discharge, in 2-month intervals from Feb. 1, 2011 to Mar. 26, 2019. The dotted line represents the
implementation date of the electronic medication reconciliation system.

people who were exposed to benzodiazepines or anti
psychotics in hospital, use of the electronic system was
associated with a significantly lower chance of patients
returning to a hospital or emergency department from a
fall or fracture after hospital discharge.
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